ChemistryCommunications Chemistry
Asymmetric rotaxanes as dual-modality supramolecular imaging agents for targeting cancer biomarkers
F. D'orchymont and J. P. Holland
Discover the groundbreaking research by Faustine d'Orchymont and Jason P. Holland, exploring the innovative synthesis of bimodal and mechanically interlocked rotaxane-based imaging agents aimed at targeting prostate cancer biomarkers. This study showcases the development of a dual-modality imaging agent that can revolutionize cancer diagnostics.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
Recent progress in the development of nanomaterials targeting multiple cancer metabolic pathways: a review of mechanistic approaches for cancer treatment
L. Zhang, B. Zhai, et al.
Medicine and Health
Metallo-sideromycin as a dual functional complex for combating antimicrobial resistance
C. Wang, Y. Xia, et al.
Medicine and Health
Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy
J. Yi, O. Tavana, et al.
Chemistry
Switchable supramolecular helices for asymmetric stereodivergent catalysis
R. Chen, A. Hammoud, et al.
